The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
kang ke zhi liao man xing chong xue xing xin li shuai jie liao xiao guan cha
Author(s): 
Pages: 1160-1161
Year: Issue:  10
Journal: Research of Traditional Chinese Medicine

Keyword:  充血性心力衰竭 β-受体阻滞剂 康可;
Abstract: 目的观察康可治疗慢性充血性心力衰竭(CHF)的临床疗效及安全性。方法将112例CHF病人随机分为对照组与治疗组。对照组采用常规治疗(强心、利尿、扩血管),治疗组在常规治疗基础上加用康可治疗。结果对照组与观察组在治疗后4周疗效无统计学意义(P>0.05),在治疗后6个月治疗组显著优于对照组(P<0.05)。结论康可可显著改善CHF病人的心功能及远期预后。
Related Articles
No related articles found